Dr. Marc Bonaca and I discussed the STRIDE trial. Semaglutide improves functional outcomes in DM pts with symptomatic PAD, addressing a critical unmet need. March 29, 2025 Disclosures: TBD
Ajay J. Kirtane and Dr. C Michael Gibson Discuss: ECLIPSEA Large-Scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation October 29, 2024 Disclosures: TBD
Dr. Dirk-Jan van Ginkel and Dr. C Michael Gibson Discuss: POPular PAUSE TAVI – Continuation or interruption of oral anticoagulation during TAVI? August 31, 2024 Disclosures: TBD
Dr. Johanne Silvain, Dr. Gilles Montalescot and Dr. C Michael Gibson Discuss: ABYSS – Beta blocker interruption in post-myocardial infarction patients August 30, 2024 Disclosures: TBD
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: CLEAR OUTCOMES subanalysis on predicting CV events November 13, 2023 Disclosures: TBD
Dr. Richard Wright and Dr. C. Michael Gibson Discuss: The Genetic / Mendalian randomization (natures randomized trial) data that supports the efficacy of Acoramadis in amyloidosis and the potential for amyloid regression with therapy November 13, 2023 Disclosures: TBD
Dr. Charalambos Antoniades and Dr. C. Michael Gibson Discuss: Novel AI Technology to Improve Risk Stratification of Patients Without Obstructive Coronary Artery Disease Undergoing CCTA: The Oxford Risk Factors and Non-Invasive Imaging (ORFAN) Study November 13, 2023 Disclosures: TBD
Dr. Alexander Fanaroff Presents: A Cluster Randomized Trial of Automated Referral to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients November 13, 2023 Disclosures: TBD
Dr. Daniel Judge and Dr. C. Michael Gibson: Acoramidis from bench to bedside November 12, 2023 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Efficacy and Safety of Lepodisiran: An Extended Duration Short-Interfering RNA Targeting Lipoprotein (a) November 12, 2023 Disclosures: TBD
